Patient
SITE001-0068
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE001 (USA) (Dr. Reyes)
consented 2025-11-16
Adverse events
5
Serious AEs
1
Open data queries
0
Luna dropout signal
+0.0
Adverse events 5
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-01-23 (study day 241); relationship: RELATED
Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-12-22 (study day 209); relationship: NOT RELATED
Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-10-19 (study day 145); relationship: not assessed
Grade 4 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-10-03 (study day 129); relationship: NOT RELATED; serious criteria: life-threatening
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-09-29 (study day 125); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
Messages
0
Escalations
0
Check-ins
0
last —
Mood ø
—
of 5
Adherence · 7d
—